TERT Promoter Mutations Are Predictive of Aggressive Clinical Behavior in Patients with Spitzoid Melanocytic Neoplasms

Controversies in the Evaluation and Management of Atypical Melanocytic Proliferations in Children, Adolescents, and Young Adults

(2017) Damon Reed et al.   Journal of the National Comprehensive Cancer Network

TERT promoter mutations are associated with distant metastases in papillary thyroid carcinoma

(2015) G. Gandolfi et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Association ofTERTPromoter Mutation 1,295,228 C>T WithBRAFV600E Mutation, Older Patient Age, and Distant Metastasis in Anaplastic Thyroid Cancer

(2015) Xiaoguang Shi et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

The Genomic Landscape of Childhood and Adolescent Melanoma

(2015) Charles Lu et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

RE: TERT Promoter Mutation Status as an Independent Prognostic Factor in Cutaneous Melanoma

(2015) H. Populo et al.   JNCI-Journal of the National Cancer Institute

TERT promoter mutation designates biologically aggressive primary glioblastoma

(2015) Jason T. Huse   NEURO-ONCOLOGY

RE: TERT Promoter Mutation Status as an Independent Prognostic Factor in Cutaneous Melanoma

(2015) H. Populo et al.   JNCI-Journal of the National Cancer Institute

Histomorphologic Assessment and Interobserver Diagnostic Reproducibility of Atypical Spitzoid Melanocytic Neoplasms With Long-term Follow-up

(2014) Pedram Gerami et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

TERT Promoter Mutations in Skin Cancer: The Effects of Sun Exposure and X-Irradiation

(2014) Helena Pópulo et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

TERT Promoter Mutation Status as an Independent Prognostic Factor in Cutaneous Melanoma

(2014) Klaus G. Griewank et al.   JNCI-Journal of the National Cancer Institute

Atypical Spitz tumours and sentinel lymph node biopsy: a systematic review

(2014) Aimilios Lallas et al.   LANCET ONCOLOGY

TERT promoter mutations: a novel independent prognostic factor in primary glioblastomas

(2014) Matthias Simon et al.   NEURO-ONCOLOGY

Telomerase promoter mutations in cancer: an emerging molecular biomarker?

(2014) João Vinagre et al.   VIRCHOWS ARCHIV

Telomerase reverse transcriptase promoter mutations in primary cutaneous melanoma

(2014) Barbara Heidenreich et al.   Nature Communications

Kinase fusions are frequent in Spitz tumours and spitzoid melanomas

(2014) Thomas Wiesner et al.   Nature Communications

Outcomes of Atypical Spitz Tumors With Chromosomal Copy Number Aberrations and Conventional Melanomas in Children

(2013) Pedram Gerami et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

Pediatric melanoma: Analysis of an international registry

(2013) Bruce J. Averbook et al.   CANCER

Methylation of the TERT promoter and risk stratification of childhood brain tumours: an integrative genomic and molecular study

(2013) Pedro Castelo-Branco et al.   LANCET ONCOLOGY

Recurrent BRAF kinase fusions in melanocytic tumors offer an opportunity for targeted therapy

(2013) Thomas Botton et al.   Pigment Cell & Melanoma Research

TERT Promoter Mutations in Familial and Sporadic Melanoma

(2013) S. Horn et al.   SCIENCE

Highly Recurrent TERT Promoter Mutations in Human Melanoma

(2013) F. W. Huang et al.   SCIENCE

A Proposal for Improving Multicolor FISH Sensitivity in the Diagnosis of Malignant Melanoma Using New Combined Criteria

(2012) Katrin Kerl et al.   AMERICAN JOURNAL OF DERMATOPATHOLOGY

A Highly Specific and Discriminatory FISH Assay for Distinguishing Between Benign and Malignant Melanocytic Neoplasms

(2012) Pedram Gerami et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

Agreement of Dermatopathologists in the Evaluation of Clinically Difficult Melanocytic Lesions: How Golden Is the ‘Gold Standard’?

(2012) R.P. Braun et al.   DERMATOLOGY

Genetic alterations in RAS-regulated pathway in acral lentiginous melanoma

(2012) Joan A. Puig-Butillé et al.   EXPERIMENTAL DERMATOLOGY

Regulation of the human catalytic subunit of telomerase (hTERT)

(2012) Michael Daniel et al.   GENE

Sentinel lymph node metastasis is not predictive of poor outcome in patients with problematic spitzoid melanocytic tumors

(2012) Tawny Hung et al.   HUMAN PATHOLOGY

Enhanced Detection of Spitzoid Melanomas Using Fluorescence In Situ Hybridization With 9p21 as an Adjunctive Probe

(2011) Bryan Gammon et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

Hallmarks of Cancer: The Next Generation

(2011) Douglas Hanahan et al.   CELL

Malignancy without immortality? Cellular immortalization as a possible late event in melanoma progression

(2011) Julia K. Soo et al.   Pigment Cell & Melanoma Research

Melanocytic Tumors of Uncertain Malignant Potential

(2010) Lorenzo Cerroni et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

Melanoma and Melanocytic Tumors of Uncertain Malignant Potential in Children, Adolescents and Young Adults-The Stanford Experience 1995-2008

(2010) David R. Berk et al.   PEDIATRIC DERMATOLOGY

Fluorescence In Situ Hybridization (FISH) as an Ancillary Diagnostic Tool in the Diagnosis of Melanoma

(2009) Pedram Gerami et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

The atypical Spitz tumor of uncertain biologic potential

(2009) Mathew W. Ludgate et al.   CANCER

Sentinel Lymph Node Biopsy for Patients With Diagnostically Controversial Spitzoid Melanocytic Tumors?

(2008) Klaus J. Busam et al.   ADVANCES IN ANATOMIC PATHOLOGY

Spitzoid melanoma in children: clinicopathological study and application of immunohistochemistry as an adjunct diagnostic tool

(2008) Sabela Paradela et al.   JOURNAL OF CUTANEOUS PATHOLOGY